In the Neuromodulation Lab, we believe that the participants in our studies are our best collaborators. Your participation allows us to have you as an advisor as we develop our treatments for optimal use. We have designed many of our trials to allow you to participate from home in order to reduce the burden of time and travel.

RECOVER-NEURO

We are glad to be leading the intervention for the RECOVER-NEURO trial launched through enrolling centers across the US to test solutions for the cognitive impairment that can occur in Long COVID (Post-Acute Sequelae of SARS-CoV-2 infection), including tDCS. Our RECOVER-NEURO team is led by Leigh E. Charvet, PhD and Giuseppina Pilloni, PhD, along with Shayna Pehel, Tim Ko, Erica Kreisberg, Matt Lustberg, and Luis Fernandez. For more information, read RECOVER-NEURO enrolls first participant in trial.

Our Research Initiatives

Current research initiatives led by the Neuromodulation Lab include the following:

• CAN-MS: A program of tDCS for reducing cannabis use in MS
  • seeking women living with MS and interested in decreasing cannabis (marijuana) use
  • at-home tDCS treatment study
• COPE-MS: Intra-individual variability in cognitive performance as a marker of prodromal MS
  • seeking participants who are recently diagnosed with MS or at risk for developing MS
  • at-home measurements of cognitive and walking speed
  • advanced neuroimaging markers of risk
• GAIT-HUB: Gait Assessment with Innovative Technologies - Home-Based Use Benefit
  • seeking participants with MS to help us advance new technologies to measure and monitor walking at home
  • validation of wearable sensors to assess gait in the clinic and at home
• PoNSTEP: PoNS Therapeutic Experience Program
  • seeking participants with MS who have changes in their walking abilities
  • PoNS device and physical therapy treatment study

Learn more about our team’s research by reading the latest publications.